News & Insights

The Israeli Parliament (the Knesset) has voted, in a first reading, in favor of a proposed amendment to the Israeli Patents Law (1967) that aims to increase the global competitive advantage of Israeli generic pharmaceutical companies.

September 1st, although often associated with the commencement of WW2, also marks the official “back-to-school” day in Israel – and in many other countries around the world. This provides for an excellent opportunity to acknowledge those inventions and patents that have shaped the way in which we teach and learn – namely, how (and on what) do we stage knowledge?

The unprecedented success of the COVID-19 vaccines, both therapeutically and commercially, has prompted fierce competition. Multiple companies around the world are fighting to claim patent rights related to these vaccines.

As the New York Times recently reported, ten years have passed since the first publication of a ground-breaking paper about the potential usefulness of CRISPR, “the gene-editing technology [that] has led to innovations in medicine, evolution and agriculture — and raised profound ethical questions about altering human DNA.”

Antibody-based therapeutics play a central role in medicine and patent protection is critical to reaping the financial benefits from such successful therapeutic agents. Recent occurrences suggest that the barriers to securing broad patent protection in the US have increased. Innovative companies should develop and practice proper patent strategies ensuring that they receive the proper exclusionary patent protection that antibody-related innovations deserve.

A trademark clearance search is an important and recommended preliminary step before filing a trademark application. A trademark clearance search helps to identify any issues with a proposed mark before filing. A search can cover a proposed company name, brand name, product name, slogan, or logo.

For the first time in history - Australian court rules that artificial intelligence can be registered as an inventor in a patent Sounds like science fiction? Science - Yes, Fiction - No!